Today: 29 April 2026
Nebius stock (NBIS) ends higher as Nvidia Rubin rollout news sinks in
9 January 2026
1 min read

Nebius stock (NBIS) ends higher as Nvidia Rubin rollout news sinks in

NEW YORK, Jan 8, 2026, 21:04 EST — Market closed

  • NBIS rose 1.1% to $97.30 on Thursday
  • Nebius said it will offer Nvidia’s Vera Rubin NVL72 platform from H2 2026
  • Next focus: timing of Rubin availability and Nebius’ next results window

Nebius Group N.V. shares climbed 1.1% on Thursday, closing at $97.30. The move extended a volatile week for the AI cloud company, which announced it will be one of the first Nvidia Cloud Partners to roll out Nvidia’s Vera Rubin NVL72 platform. The stock swung between $96.06 and $102.49, with roughly 13.0 million shares changing hands.

The announcement lands at a moment when investors are picking through the AI infrastructure trade again, trying to separate hardware hype from delivery schedules. For smaller “neocloud” providers like Nebius, access to next-generation GPUs — chips used to train and run AI models — can shape both customer wins and capital requirements.

Rubin matters because it brings the next spending cycle into focus. Nebius is telling customers to expect Rubin-based systems in the second half of 2026. It’s a long runway, where delays, supply constraints, or changes in demand could quickly upend those plans.

In its statement, CEO Arkady Volozh said Nebius was “proud to be one of the first” to offer Vera Rubin GPUs. Nvidia executive Dave Salvator added that “agentic AI” will demand infrastructure built for “scale” and “cost efficiency.” (Agentic AI is shorthand for systems that can plan and take actions across steps, not just answer prompts.) Business Wire

Nvidia’s Rubin platform made its debut at CES this week, with CEO Jensen Huang confirming the Vera Rubin NVL72 has entered production, according to tech press reports.

Nebius isn’t the only one pushing Rubin-linked messaging. Other Nvidia-connected firms, like AI infrastructure specialist CoreWeave and server manufacturer Super Micro Computer, have sparked investor interest, touting Rubin availability and related expansions.

Nebius has positioned itself as a specialist in GPU-heavy computing, citing multi-billion dollar deals with Microsoft and Meta as key drivers for its growth, Reuters reported. Co-founder Roman Chernin told Reuters the firm aims to lock in 2.5 gigawatts of contracted power by the end of 2026 across the U.S. and Europe.

Still, the deal carries the usual risks: heavy upfront capital costs, dependence on Nvidia’s hardware plans, and fierce competition from hyperscalers like Amazon and Google, who can package AI computing with wider cloud services. Miss a delivery deadline or see AI interest wane, and you’re stuck with idle capacity and mounting financing bills.

Markets are turning their attention to new CES headlines through Jan. 9, then shifting focus to Nebius’ next earnings report, anticipated around Feb. 18 per Zacks’ calendar. Investors will look for clues on demand, capex, and how fast customers are locking in orders beyond the 2026 GPU cycle.

Stock Market Today

  • Consumer interest rates and inflation shifts under Jerome Powell's Fed tenure
    April 29, 2026, 4:15 PM EDT. During Jerome Powell's eight-year leadership of the Federal Reserve, consumer interest rates and inflation saw notable changes. The Fed increased the key overnight lending rate 15 times and lowered it 11 times, moving the rate from near zero during the pandemic to a peak of 5.25%-5.50% in mid-2023 to counter inflation. Consumer prices rose 32%, with something costing $1,000 in 2018 priced at $1,323 in 2024. Online high-yield savings accounts improved yields from 1.53% in 2018 to an average of 3.43% this year, with top offers at 4.2%-4.4%. The Federal Open Market Committee balances economic data, geopolitical and fiscal factors when setting rates that affect savings returns, borrowing costs, and consumer prices.

Latest article

Dow Drops as Fed Split and Oil Surge Put Big Tech’s $10 Trillion AI Test on the Line

Dow Drops as Fed Split and Oil Surge Put Big Tech’s $10 Trillion AI Test on the Line

29 April 2026
New York, April 29, 2026, 4:05 PM EDT Wall Street’s April rally stalled on Wednesday as oil jumped, the Federal Reserve held interest rates steady in a split decision, and investors waited for earnings from Microsoft, Alphabet, Amazon and Meta Platforms after the bell. The timing is awkward. The Fed’s vote showed rare internal strain just as four of the market’s largest artificial-intelligence spenders are due to tell investors whether their heavy data-center outlays are turning into revenue. Reuters reported the four companies together represent more than $10 trillion in market value and about 17% of the S&P 500. Delayed
Amazon Earnings Beat Estimates as AWS AI Growth Hits 15-Quarter High

Amazon Earnings Beat Estimates as AWS AI Growth Hits 15-Quarter High

29 April 2026
Amazon reported first-quarter revenue of $181.5 billion, up 17%, with Amazon Web Services sales jumping 28% to $37.6 billion. Net income reached $30.3 billion, boosted by a $16.8 billion pre-tax gain from Anthropic investments. Free cash flow fell to $1.2 billion as AI-related spending surged. Amazon forecast second-quarter sales of $194 billion to $199 billion, above Wall Street expectations.
Vita Coco Stock Surges After COCO Earnings Beat and Coconut Water Demand Lifts 2026 Outlook

Vita Coco Stock Surges After COCO Earnings Beat and Coconut Water Demand Lifts 2026 Outlook

29 April 2026
Vita Coco shares jumped 27% Wednesday after first-quarter net sales rose 37% to $180 million, beating analyst expectations. The company raised its 2026 revenue outlook to $720–$735 million and lifted adjusted EBITDA guidance. Diluted earnings reached $0.50 per share, up from $0.31 a year earlier. Gross margin improved to 39.9% despite higher logistics and tariff costs.
Bank of America stock climbs as India regulator notice lands before earnings — what to watch for BAC
Previous Story

Bank of America stock climbs as India regulator notice lands before earnings — what to watch for BAC

GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom
Next Story

GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom

Go toTop